A case of successful treatment of medication-related osteonecrosis of the jaw with conservative treatment for pathological mandibular fracture

被引:0
|
作者
Tsuhako, Kota [1 ]
Sekido, Katsuhisa [2 ,3 ,4 ]
Ando, Takumi [1 ]
Okita, Michiko [1 ]
Harada, Masashi [1 ]
Hariya, Yasushi [1 ]
机构
[1] Teine Keijinkai Hosp, Dept Oral & Maxillofacial Surg, 1-12-1-40 Maeda,Teine Ku, Sapporo, Hokkaido 0068555, Japan
[2] Toyama Red Cross Hosp, Dept Dent & Oral Surg, 2-1-58 Ushijimahonnmachi, Toyama 9300859, Japan
[3] Univ Toyama, Fac Med, Dept Oral & Maxillofacial Surg, 2630 Sugitani, Toyama, Toyama 9300194, Japan
[4] Univ Toyama, Fac Med, Comprehens Oral Sci, 2630 Sugitani, Toyama, Toyama 9300194, Japan
关键词
Conservative treatment; Medication-related osteonecrosis; Pathological mandibular fracture; Restricting mouth opening; SURGEONS POSITION PAPER; AMERICAN ASSOCIATION;
D O I
10.1016/j.ijscr.2024.109822
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Surgical therapy is effective for medication-related osteonecrosis of the jaw. However, appropriate conservative treatment options are still important for cases in which surgery is contraindicated. We report a case of medication-related osteonecrosis of the jaw successfully treated conservatively for a pathological mandibular fracture. Presentation of case: An 84-year-old female patient presented to our department with a chief complaint of inadequate healing of an extraction tooth socket. She had been taking minodronic acid hydrate for approximately five years for osteoporosis. The clinical examination revealed erythema, diffuse swelling of the left mandibular angle, erythema of the buccal gingiva adjacent to the left mandibular first molar, and fistula formation. Although surgery was recommended, the patient declined to proceed. Therefore, a conservative treatment was initiated. A pathological fracture of the inferior mandibular margin was observed one month after the initial visit. Mouth opening was restricted for six months using a bandage. Two months after the pathological fracture, the inferior margin of the fracture was aligned. Five months later, the inferior margin continued. One year later, the bony union of the fracture was observed. Discussion: Conservative treatment and restricting mouth opening was effective in our case. Three years and seven months after the pathological fracture, no new sequestrum formation was observed, and the patient was doing well. Conclusion: Conservative treatment can be effective for medication-related osteonecrosis of the jaw with severe cases.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Conservative Management of Severe Medication-Related Osteonecrosis of the Jaw With Pathological Fracture
    Varidel, Alistair
    Wong, Eva
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2022, 33 (03) : E329 - E333
  • [2] Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw
    Chopra, Kirti
    Malhan, Namrita
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) : E469 - E477
  • [3] Conservative treatment of refractory medication-related osteonecrosis of the jaw using the PENTO protocol: A case report
    Melian Rivas, Andres Noah
    Rojas Donaire, Javiera Alejandra
    [J]. ODONTOESTOMATOLOGIA, 2021, 23 (38):
  • [4] Spontaneous Recovery of Pathological Fracture Caused by Medication-Related Osteonecrosis of the Jaw
    Jung, Joon Hyeok
    Kim, Je Seong
    Kim, Bong Chul
    Lee, Jun
    Lim, Hun Jun
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2024, 35 (01) : 17 - e16
  • [5] Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series
    Aljohani, Suad
    Troeltzsch, Matthias
    Hafner, Sigurd
    Kaeppler, Gabriele
    Mast, Gerson
    Otto, Sven
    [J]. ORAL DISEASES, 2019, 25 (02) : 497 - 507
  • [6] Treatment of medication-related osteonecrosis of the jaw with cell therapy
    Bouland, Cyril Lucien
    Javadian, Rokneddine
    Gilis, Sarah
    Yanni, Antoine
    Le Clercq, Maxime
    Mestrallet, Pierre
    Kampouridis, Stelianos
    Bron, Dominique
    Lalmand, Martin
    Vanden Eynden, Xavier
    Boutremans, Edward
    Dequanter, Didier
    Loeb, Isabelle
    Philippart, Pierre
    Lagneaux, Laurence
    Meuleman, Nathalie
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [7] Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)
    Ristow, Oliver
    Otto, Sven
    Troeltzsch, Matthias
    Hohlweg-Majert, Bettina
    Pautke, Christoph
    [J]. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2015, 43 (02) : 290 - 293
  • [8] Prognosis of Medication-Related Osteonecrosis of the Jaw with Surgical Treatment
    Kobayashi, Eizaburo
    Takahashi, Haruka
    Igarashi, Kensuke
    Katagiri, Hiroki
    Haga-Tsujimura, Maiko
    Ogura, Ichiro
    Nakahara, Ken
    Tanaka, Akira
    [J]. JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (01) : 39 - 46
  • [9] Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
    Seluki, Rial
    Seluki, Moshe
    Vaitkeviciene, Inga
    Jagelaviciene, Egle
    [J]. JOMR-JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, 2023, 14 (04):
  • [10] Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
    Jowett, Adam
    Abdullakutty, Anwer
    Bailey, Malcolm
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2015, 10 : 162 - 165